A number of 6'-methylidene-2,3-dihydro-1H-spiro[pyridine-4,5'-thieno[2,3-d]pyrimidin]-4'(3'H)-one derivatives, obtained as major products of a domino reaction between 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidines and electron-deficient alkynes, were characterized for their acid-base properties and lipophilicity and evaluated for the antimicrobial activity against a number of clinical isolates of bacterial and fungal strains. The cytotoxicity against four tumor cell lines was also screened for some compounds. The dissociation constants (pK a) and partition coefficients (log P) in 1-octanol–water system were determined using a potentiometric technique. The negative difference between the observed and calculated log P values could be explained in the light of the conformational rigidity. Most of the studied compounds showed a moderate and selective activity against Gram-positive bacteria strains (S. agalactiae, E. faecalis, S. epidermidis), whereas did not exhibit any effect against Gram-negative bacteria and fungi at the maximum test concentration (500 μM). Implications of the physicochemical properties in modulating the antimicrobial activity and cytotoxicity of the examined spirocyclic thieno[2,3-d]pyrimidin-4(3H)-one derivatives are also discussed.
Similar content being viewed by others
References
Perron, F.; Albizati, K. F. Chem. Rev. 1989, 89, 1617.
Marson, C. M. Chem. Soc. Rev. 2011, 40, 5514. 3. Zheng, Y.-J.; Tice, C. M. Expert Opin. Drug Discovery 2016, 11, 831.
Zheng, Y.; Tice, C. M.; Singh S. B. Bioorg. Med. Chem. Lett. 2014, 24, 3673.
Khan, A. R.; Parrish, J. C.; Fraser, M. E.; Smith, W. W.;
Bartlett, P. A.; James, M. N. G. Biochemistry 1998, 37, 16839.
Fraser, M. E.; Meyer, J. H.; Bartlett, P. A.; James, M. N. G. Adv. Exp. Med. Biol. 1998, 436, 355.
Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. J. Med. Chem. 2002, 45, 2615.
Lovering, F.; Bikker, J.; Humblet, C. J. Med. Chem. 2009, 52, 6752.
Petersen, A. B.; Rønnest, M. H.; Larsen, T. O.; Clausen, M. H. Chem. Rev. 2014, 114, 12088.
Premachandra, I. D. U. A.; Scott, K. A.; Shen, C.; Wang, F.; Lane, S.; Liu, H.; Van Vranken, D. L. ChemMedChem 2015, 10, 1672.
Basarab, G. S.; Doig, P.; Galullo, V.; Kern, G.; Kimzey, A.; Kutschke, A.; Newman, J. P.; Morningstar, M.; Mueller, J.; Otterson, L.; Vishwanathan, K.; Zhou, F.; Gowravaram, M. J. Med. Chem. 2015, 58, 6264.
Meng, L.-H.; Wang, C.-Y.; Mándi, A.; Li, X.-M.; Hu, X.-Y.; Kassack, M. U.; Kurtán, T.; Wang, B. -G. Org. Lett. 2016, 18, 5304.
Neelamkavil, S. F.; Agrawal, S.; Bara, T.; Bennett, C.; Bhat, S.; Biswas, D.; Brockunier, L.; Buist, N.; Burnette, D.; Cartwright, M.; Chackalamannil, S.; Chase, R.; Chelliah, M.; Chen, A.; Clasby, M.; Colandrea, V. J.; Davies, I. W.; Eagen, K.; Guo, Z.; Han, Y.; Howe, J.; Jayne, C.; Josien, H.; Kargman, S.; Marcantonio, K.; Miao, S.; Miller, R.; Nolting, A.; Pinto, P.; Rajagopalan, M.; Ruck, R. T.; Shah, U.; Soriano, A.; Sperbeck, D.; Velazquez, F.; Wu, J.; Xia, Y.; Venkatraman, S. ACS Med. Chem. Lett. 2015, 7, 111.
Voskressensky, L. G.; Kovaleva, S. A.; Borisova, T. N.; Eresko, A. B.; Tolkunov, V. S.; Tolkunov, S. V.; Listratova, A. V.; de Candia, M.; Altomare, C.; Varlamov, A. V. Chem. Heterocycl. Compd. 2013, 49, 930. [Khim. Geterotsikl. Soedin. 2013, 995.]
Voskressensky, L. G.; Kovaleva, S. A.; Borisova, T. N.; Titov, A. A.; Toze, F.; Listratova, A. V.; Khrustalev, V. N.; Varlamov, A. V. Chem. Heterocycl. Compd. 2015, 51, 17. [Khim. Geterotsikl. Soedin. 2015, 51, 17.]
Voskressensky, L. G.; Borisova, T. N.; Kovaleva, S. A.; Listratova, A. V.; Kulikova, L. N.; Khrustalev, V. N.; Ovcharov, M. V.; Varlamov, A. V. Russ. Chem. Bull., Int. Ed. 2012, 61, 370. [Izv. Akad. Nauk, Ser. Khim. 2012, 368.]
Avdeef, A.; Box, K. J.; Comer, J. E. A.; Hibbert, C.; Tam, K. Y. Pharm. Res. 1998, 15, 209.
de Candia, M.; Fossa, P.; Cellamare, S., Mosti, L.; Carotti, A.; Altomare, C. Eur. J. Pharm. Sci. 2005, 26, 78.
Avdeef, A.; Box, K. J.; Comer, J. E. A.; Gilges, M.: Hadley, M.; Hibbert, C.; Patterson, W.; Tam, K. Y. J. Pharm. Biomed. Anal. 1999, 20, 631.
Osinga, M. J. Am. Chem. Soc. 1979, 101, 1621.
van de Waterbeemd, H.; Testa, B. In Advances in Drug Design; Testa, B., Ed.; Academic Press: London, 1987, Vol. 16, p. 85.
Altomare, C.; Carrupt, P.-A.; El Tayar, N.; Testa, B.; Nagatsu, T. Helv. Chim. Acta 1991, 74, 290.
Trotter, J. Can. J. Chem. 1959, 37, 1487.
Ross, L.; Barclay, B.; Brownstein, S.; Gabe, E. J.; Lee, F. L. Can. J. Chem. 1984, 62, 1358.
Hansch, C.; Leo, A. Pomona College Medicinal Chemistry Project; Comtex Scientific Co.: New York, 1983.
Performance Standard for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A9; CLSI: Wayne, 2006, 9th ed.
Berridge, M. V.; Herst, P. M.; Tan, A. S. Biotechnol. Annu. Rev. 2005, 11, 127.
Takács-Novák, K.; Box, K. J.; Avdeev, A. Int. J. Pharm. 1997, 151, 235.
Krämer, S. D.; Gautier, J.-C.; Saudemon, P. Pharm. Res. 1998, 15, 1310.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2017, 53(3), 357–363
Rights and permissions
About this article
Cite this article
de Candia, M., Altamura, C., Denora, N. et al. Physicochemical properties and antimicrobial activity of new spirocyclic thieno[2,3-d]pyrimidin-4(3H)-one derivatives. Chem Heterocycl Comp 53, 357–363 (2017). https://doi.org/10.1007/s10593-017-2057-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-017-2057-1